Company InDex Pharmaceuticals Holding AB Nasdaq Stockholm
Equities
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- SEK | - |
Business Summary
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals for Immunological Diseases
100.0
%
| 0 | nan % | 98 | 100.0 % | - |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
100.0
%
| - | - | 98 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jenny Sundqvist
CEO | Chief Executive Officer | 53 | 31/12/22 |
Johan Gileus
DFI | Director of Finance/CFO | 59 | 30/04/17 |
Charlotte Admyre
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Eva Arlander
PRN | Corporate Officer/Principal | 60 | 01/05/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
BRD | Director/Board Member | 74 | 31/12/15 |
Director/Board Member | 68 | 31/12/10 | |
Chairman | 72 | 31/12/10 | |
Karin Bernadotte
BRD | Director/Board Member | 61 | 31/12/21 |
Marlene Forsell
BRD | Director/Board Member | 48 | 31/03/20 |
Director/Board Member | 56 | 31/12/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 532,687,650 | 332,794,895 ( 62.47 %) | 0 | 62.47 % |
Company contact information
InDex Pharmaceuticals Holding AB
Berzelius vaeg 13
171 65, Solna
+46 8 12 20 38 50
http://www.indexpharma.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- INDEX Stock
- Stock
- Company InDex Pharmaceuticals Holding AB